IDEAYA Biosciences, Inc. (IDYA)
USD 25.59
(-2.81%)
USD 25.59
(-2.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 23.38 Million | 50.93 Million | 27.94 Million | 19.53 Million | - | - |
| Cost of Revenue | 129.5 Million | 2.1 Million | 1.72 Million | 39.69 Million | 1.24 Million | 886 Thousand |
| Gross Profit | -106.12 Million | 48.83 Million | 26.21 Million | -20.16 Million | -1.24 Million | -886 Thousand |
| Operating Expenses | 157.81 Million | 113.43 Million | 78.2 Million | 54.88 Million | 44.27 Million | 36.41 Million |
| Selling, General and Administrative Expenses | 28.3 Million | 23.89 Million | 20.05 Million | 15.18 Million | 9.95 Million | 4.66 Million |
| Research and Development Expenses | 129.5 Million | 89.53 Million | 58.15 Million | 39.69 Million | 34.31 Million | 31.74 Million |
| Other Expenses | - | - | - | - | 8000.00 | 77 Thousand |
| Cost and Expenses | 157.81 Million | 113.43 Million | 78.2 Million | 54.88 Million | 44.27 Million | 36.41 Million |
| Operating Income | -134.42 Million | -62.5 Million | -50.26 Million | -35.34 Million | -44.27 Million | -36.41 Million |
| Interest Expense | - | 3.84 Million | - | 849 Thousand | - | - |
| Income Tax Expense | - | -3.84 Million | -2.23 Million | -2.23 Million | -3.53 Million | 2.07 Million |
| Earnings before Tax | -112.96 Million | -58.65 Million | -49.76 Million | -34.49 Million | -41.97 Million | -34.34 Million |
| Net Income | -112.96 Million | -54.8 Million | -47.53 Million | -32.26 Million | -38.44 Million | -34.34 Million |
| Earnings Per Share Basic | -1.96 | -1.32 | -1.35 | -1.31 | -1.90 | -2.41 |
| Earnings Per Share Diluted | -1.96 | -1.32 | -1.35 | -1.31 | -1.90 | -2.41 |
| Weighted Average Shares Outstanding | 57.51 Million | 41.44 Million | 35.25 Million | 24.72 Million | 20.23 Million | 14.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.51 Million | 41.44 Million | 35.25 Million | 24.72 Million | 20.23 Million | 14.24 Million |
| Gross Margin | -4.54 | 0.96 | 0.94 | -1.03 | - | - |
| EBIT Margin | -5.58 | -1.23 | -1.80 | -1.81 | - | - |
| Profit Margin | -4.83 | -1.08 | -1.70 | -1.65 | - | - |
| EBITDA | -130.42 Million | -60.4 Million | -48.54 Million | -33.96 Million | -43.02 Million | -35.53 Million |
| Earnings Before Tax Margin | -5.75 | -1.23 | -1.80 | -1.81 | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 23.38 Million | 3.92 Million | 8.03 Million |
| Cost of Revenue | - | 1.09 Million | 1.08 Million | 4 Million | 1.02 Million | 986 Thousand |
| Gross Profit | - | -1.09 Million | -1.08 Million | 19.37 Million | 2.89 Million | 7.05 Million |
| Operating Expenses | 66.89 Million | 63.83 Million | 51.01 Million | 157.81 Million | 45.83 Million | 41.56 Million |
| Selling, General and Administrative Expenses | 9.74 Million | 9.29 Million | 8.21 Million | - | 7.06 Million | 7.86 Million |
| Research and Development Expenses | 57.15 Million | 54.53 Million | 42.8 Million | - | 38.77 Million | 33.7 Million |
| Other Expenses | - | -54.53 Million | - | - | - | - |
| Cost and Expenses | 66.89 Million | 64.92 Million | 51.01 Million | 157.81 Million | 45.83 Million | 41.56 Million |
| Operating Income | -66.89 Million | -64.92 Million | -51.01 Million | -134.42 Million | -41.91 Million | -33.52 Million |
| Interest Expense | - | - | - | 21.46 Million | 25.06 Million | - |
| Income Tax Expense | - | - | -1.08 Million | 3.84 Million | 5.62 Million | -1.02 Million |
| Earnings before Tax | -51.82 Million | -52.77 Million | -39.57 Million | -112.96 Million | -33.95 Million | -27.44 Million |
| Net Income | -51.82 Million | -52.77 Million | -39.57 Million | -112.96 Million | -33.95 Million | -27.44 Million |
| Earnings Per Share Basic | -0.60 | -0.68 | -0.53 | - | -0.52 | -0.46 |
| Earnings Per Share Diluted | -0.60 | -0.68 | -0.53 | - | -0.52 | -0.46 |
| Weighted Average Shares Outstanding | 86.18 Million | 77.96 Million | 75.1 Million | 57.51 Million | 65.24 Million | 59.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.18 Million | 77.96 Million | 75.1 Million | 57.51 Million | 65.24 Million | 59.99 Million |
| Gross Margin | - | - | - | 0.83 | 0.74 | 0.88 |
| EBIT Margin | - | - | - | - | -10.42 | -4.17 |
| Profit Margin | - | - | - | -4.83 | -8.66 | -3.41 |
| EBITDA | -66.89 Million | -63.83 Million | -51.01 Million | - | -40.89 Million | -33.52 Million |
| Earnings Before Tax Margin | - | - | - | -5.75 | -10.68 | -4.17 |
CTMX
OMV
GRPOF
LMDCF
KALYANIFRG
5657